Literature DB >> 33456995

The inhibitory effects of probiotics on colon cancer cells: in vitro and in vivo studies.

Fangjian Shang1, Xia Jiang1, Haobo Wang1, Shihao Chen1, Xin Wang2, Ying Liu1, Shang Guo1, Dongyun Li1, Weifang Yu3, Zengren Zhao1, Guiqi Wang1.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is the most common gastrointestinal malignancy. And probiotics may have the function of preventing colon cancer. The aim of this study was to investigate the inhibitory effects of a probiotic mixture on colorectal cancer and its potential mechanisms.
METHODS: The effects of the probiotic mixture on proliferation and metastasis of mouse colon cancer CT26 cells were assessed by probiotics and cells co-culture assay, Cell Counting Kit-8 assay, colony formation assay, wound-healing assay, as well as migration and invasion assays. And CT26 cells were also transplanted into BALB/c mice to construct transplanted tumor animal model. The mice were randomly divided into two groups, control group and probiotic mixture intragastric administration group, after injection 21 days the tumor size and infiltration of immune cells in the tumor or spleen tissues were analyzed by hematoxylin and eosin (HE) and immunohistochemistry (IHC) staining.
RESULTS: The probiotic mixture significantly inhibited the proliferation, invasion, and migration ability of CT26 cells compare to the control cells (P<0.05). In the animal experiments, the tumor volume of mice that had been fed the probiotic mixture was significantly smaller than that of the control group (P<0.05). Compared with control mice, more apoptotic cells and infiltration of immune cells were showed in the tumor tissues of the mice treated with the probiotic mixture, and an increased number of CD8+ cells in the tumor and spleen tissues but no significant change in tissues.
CONCLUSIONS: These results suggested that the probiotic mixture could inhibit the growth of CT26 tumors and induce an immune response in vivo. The probiotic mixture also inhibited the invasion, migration, and proliferation ability of CT26 cells in vitro. 2020 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  CT26 cells; Probiotic; colorectal cancer (CRC)

Year:  2020        PMID: 33456995      PMCID: PMC7807261          DOI: 10.21037/jgo-20-573

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  21 in total

1.  Probiotic supplementation attenuates the aggressiveness of chemically induced colorectal tumor in rats.

Authors:  Sandra Cristina Genaro; Luis Souza Lima de Souza Reis; Sabrina Karen Reis; Eduardo Augusto Rabelo Socca; Wagner José Fávaro
Journal:  Life Sci       Date:  2019-10-11       Impact factor: 5.037

Review 2.  Roles of the Polyphenol-Gut Microbiota Interaction in Alleviating Colitis and Preventing Colitis-Associated Colorectal Cancer.

Authors:  Yiying Zhao; Qing Jiang
Journal:  Adv Nutr       Date:  2021-03-31       Impact factor: 8.701

Review 3.  Anticancer effects of the microbiome and its products.

Authors:  Laurence Zitvogel; Romain Daillère; María Paula Roberti; Bertrand Routy; Guido Kroemer
Journal:  Nat Rev Microbiol       Date:  2017-05-22       Impact factor: 60.633

4.  Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumour-bearing mice.

Authors:  Jingtao Hu; Chunfeng Wang; Liping Ye; Wentao Yang; Haibin Huang; Fei Meng; Shaohua Shi; Zhuang Ding
Journal:  J Biosci       Date:  2015-06       Impact factor: 1.826

5.  Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro.

Authors:  Juanita Escamilla; Michelle A Lane; Vatsala Maitin
Journal:  Nutr Cancer       Date:  2012-07-25       Impact factor: 2.900

6.  Krill oil, vitamin D and Lactobacillus reuteri cooperate to reduce gut inflammation.

Authors:  M Costanzo; V Cesi; F Palone; M Pierdomenico; E Colantoni; B Leter; R Vitali; A Negroni; S Cucchiara; L Stronati
Journal:  Benef Microbes       Date:  2018-04-10       Impact factor: 4.205

Review 7.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 8.  Genomics and metagenomics of colorectal cancer.

Authors:  Charmaine Ng; Haojun Li; William K K Wu; Sunny H Wong; Jun Yu
Journal:  J Gastrointest Oncol       Date:  2019-12

9.  A case-control study of the association between metabolic syndrome and colorectal cancer: a comparison of International Diabetes Federation, National Cholesterol Education Program Adults Treatment Panel III, and World Health Organization definitions.

Authors:  Vaidehi Ulaganathan; Mirnalini Kandiah; Zalilah Mohd Shariff
Journal:  J Gastrointest Oncol       Date:  2018-08

10.  Cancer-protective effect of a synbiotic combination between Lactobacillus gasseri 505 and a Cudrania tricuspidata leaf extract on colitis-associated colorectal cancer.

Authors:  Nam Su Oh; Ji Young Lee; You-Tae Kim; Sae Hun Kim; Ju-Hoon Lee
Journal:  Gut Microbes       Date:  2020-07-14
View more
  1 in total

Review 1.  Cancer-associated inflammation: pathophysiology and clinical significance.

Authors:  Piotr Pęczek; Monika Gajda; Kacper Rutkowski; Marta Fudalej; Andrzej Deptała; Anna M Badowska-Kozakiewicz
Journal:  J Cancer Res Clin Oncol       Date:  2022-10-19       Impact factor: 4.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.